VersaBank (VBNK)
Valuation Overview•Is VersaBank Overvalued or Undervalued?
The market is pricing the stock in line with historical averages, assuming steady-state growth.
Moderate quality score of 53/100, reflecting stable operating margins and manageable leverage.
Wall Street forecasts a balanced outlook with consensus price targets near the current price.
Verdict: Average quality business weighed down by significant growth concerns.
Wall Street sentiment is generally neutral alongside robust expected earnings growth. However, capital return yields remain modest, driven predominantly by aggressive share repurchases.
VBNK demonstrates adequate business quality with stable profitability. This is backed by a fortress balance sheet, holding significant net cash ($473M) and minimal debt risk.
The company maintains stable top-line performance paired with stable bottom-line earnings. Operating efficiency remains adequate with margins around 13.6%.
| Financial Metric | Trend (12Q) | Latest Qtr | 1Y Growth | 3Y CAGR | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| Revenue | $85.6M | +7.7% | — | — | +6.2% | |
| EBITDA | $11.3M | — | +8.9% | — | — | |
| Net Income | $7.5M | -28.4% | +7.9% | — | +13.2% | |
| EPS (Diluted) | $0.23 | -39.6% | +4.4% | +1.9% | +10.6% | |
| Free Cash Flow | $22.4M | -367.7% | -173.6% | — | — |
| Metric | TTM | 3Y Avg | 5Y Avg | 10Y Avg |
|---|---|---|---|---|
| Gross Margin | 42.4% | 81.8% | 75.3% | 68.1% |
| Operating Margin | 13.6% | 35.9% | 33.0% | 29.5% |
| Net Margin | 9.3% | 25.7% | 23.5% | 22.5% |
| FCF Margin | 59.6% | -99.5% | -87.6% | -23.4% |
| Quarter | EPS Est. | EPS Act. | Surprise | EPS | Rev |
|---|---|---|---|---|---|
| Q2'26Latest | $0.26 | $0.28 | +9.2% | ||
| Q1'26 | $0.27 | $0.27 | +0.0% | ||
| Q1'26 | $0.27 | $0.27 | +0.0% | ||
| Q4'25 | $0.24 | $0.24 | +0.0% | ||
| Q3'25 | $0.20 | $0.22 | +10.0% | ||
| Q2'25 | $0.21 | $0.18 | -14.3% | ||
| Q1'25 | $0.29 | $0.20 | -31.0% | ||
| Q4'24 | $0.20 | $0.28 | +42.3% |
Total return is +68.3% (1Y), outperforming the benchmark by +47.5%
| Period | Total Return | vs S&P 500 (Alpha) | Dividend Contribution |
|---|---|---|---|
| YTD | +28.7% | +21.3% | — |
| 1Y | +68.3% | +47.5% | +0.8% |
| 3YCAGR | +37.5% | +17.7% | +3.2% |
| 5YCAGR | +13.3% | +1.5% | +3.8% |
| 10YCAGR | +18.9% | +5.0% | — |
The S&P 500 is at 30.6x trailing P/E — Expensive relative to historical averages.
Quick answers to common questions about VersaBank (VBNK) valuation, health, and returns.
Based on peer relative multiples, VersaBank appears Fair versus peers compared to industry peers.
VersaBank has multiple valuation anchors: Peer Relative Fair Value: $18.59 | Wall Street Analyst Target: $20.00 (implying +3.7% upside). A convergence of these signals offers higher conviction.
VersaBank displays fair financial health with a composite quality score of 53/100, supported by a Piotroski F-Score of 5/9, Return on Invested Capital (ROIC) of 5.4%.
VersaBank pays a 0.4% dividend yield, covered by a 11% payout ratio with 1 years of growth, supplemented by a 1.0% buyback yield.
VersaBank's current growth trajectory is Accelerating. The company achieved +7.7% 1Y revenue growth and -39.6% 1Y EPS growth, compared to its 3Y revenue CAGR of N/A.
Wall Street consensus is Buy based on 2 analysts, beating EPS expectations in 42% of recent quarters with a 1-quarter streak. The consensus price target represents a +3.7% change from current levels.
Investment risks for VersaBank include: -21.1% 1-year max drawdown. Volatility risk is characterized by a beta of 0.57x.
No. These computations are purely quantitative model outputs for informational purposes. They do not account for qualitative management shifts or macro events. Always consult a licensed RIA before buying or selling shares.
Disclaimer: This page is for informational purposes only and does not constitute financial advice. All valuation models, scores, and target estimates are automated computations under stated assumptions and should not be relied upon as the sole basis for any investment decision.